80069-015-01 : NDC 2025 Code

80069-015-01 : Lidocaine Hcl, Epinephrine ( Zone 2 )

Additionally :

You can get information about “80069-015-01” NDC code in 80069-015-01 in HTML format

HTML | 80069-015-01 in TXT (Plain Text) format

TXT | 80069-015-01 in PDF (Portable Document Format)

PDF | 80069-015-01 in XML format

XML formats.

NDC Code : 80069-015-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "80069-015-01",
    "PackageDescription": "29.5735 mL in 1 BOTTLE, PLASTIC (80069-015-01) ",
    "NDC11Code": "80069-0015-01",
    "ProductNDC": "80069-015",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Zone 2",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Lidocaine Hcl, Epinephrine",
    "DosageFormName": "GEL",
    "RouteName": "TOPICAL",
    "StartMarketingDate": "20220401",
    "EndMarketingDate": null,
    "MarketingCategoryName": "OTC MONOGRAPH DRUG",
    "ApplicationNumber": "M015",
    "LabelerName": "Dermal Source, Inc.",
    "SubstanceName": "EPINEPHRINE; LIDOCAINE HYDROCHLORIDE",
    "StrengthNumber": ".1; 40",
    "StrengthUnit": "mg/mL; mg/mL",
    "Pharm_Classes": "Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2025-11-21",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20251231",
    "StartMarketingDatePackage": "20220401",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}